LIQENZA 32MG ORAL SOLUTION 150 ML

It is not recommended for liver patients; speak with your doctor before using the LIQENZA 32MG ORAL SOLUTION 150 ML if you have any liver problems.

No, LIQENZA 32MG ORAL SOLUTION 150 ML is not recommended for pregnant women. It may be contraindicated for pregnant women, and it might cause harm to the foetus.

Your doctor will advise you to check your blood pressure and hemoglobin level and bone density because LIQENZA 32MG ORAL SOLUTION 150 ML may cause low blood pressure and anemia as a side effect.

Inform your doctor if you have any history of liver, kidney or heart problem (irregular heart beat) and seizure or cancer (other than prostate cancer). Inform your doctor if you have gastrointestinal problems or blood in urine or frequent urge for urination.

No, it is not recommended for patients with seizures. It may be contraindicated for a person with seizure.

There are no known interactions of LIQENZA 32MG ORAL SOLUTION 150 ML with other drugs.

If you have prescribed LIQENZA 32MG ORAL SOLUTION 150 ML, it is important to follow the instructions provided by your healthcare provider and to report any side effects or concerns promptly. It is advised not to consume grape juice during the treatment. Stay hydrated by consuming lots of liquids, particularly if you get diarrhea when using LIQENZA 32MG ORAL SOLUTION 150 ML. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping LIQENZA 32MG ORAL SOLUTION 150 ML. It is recommended to monitor your blood counts and bone density at regular intervals. It is not advised for women, particularly for those who are nursing or pregnant. Notify your physician if you experience frequent urges to urinate, blood in your urine, or digestive issues. Inquire with your physician if you get discomfort in the bladder or colon, as the medication may result in bladder or colon cancer as a side effect. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, LIQENZA 32MG ORAL SOLUTION 150 ML can be an effective treatment option for prostate cancer.

LIQENZA 32MG ORAL SOLUTION 150 ML is made from the molecule/combination ENZALUTAMIDE.

LIQENZA 32MG ORAL SOLUTION 150 ML is prescribed for ailments/diseases/conditions related to Oncology.